Hydroxychloroquine and Covid-19, CFM opinion: Principiology, Contradictions and Complexity
DOI:
https://doi.org/10.33448/rsd-v10i5.15005Keywords:
Autonomy; Bioethics; Ethics based on Principles; Beneficence; Maleficence.Abstract
The study proposes a principle review of the opinion related to the release of hydroxychloroquine by the Conselho Federal de Medicina (CFM). In the Opinion, CFM releases the doctor who prescribes ethical sanctions, based on the lack of other available medical resources, availability of the drug, low cost and the principle of autonomy. Disregarding the principiological relations, as well as the Biodireito, consumer protection code and other thoughts related to the civil and penal codes, it may expose the doctor to judicial imputations.
References
ANVISA. (2005). Como a ANVISA vê o uso off label de medicamentos. Agência Nacional de Vigilância Sanitária. http://antigo.anvisa.gov.br/en_US/novahome
ANVISA. (2020). Entenda a liberação de cloroquina e hidroxicloroquina - Notícias - Anvisa. Agência Nacional de Vigilância Sanitária. https://www.saude.gov.br/images/pdf/2020/marco/30/MS---0014167392---Nota-Informativa.pdf
Azambuja Loch, J., & Souza, P. V. S. (2014). Bioética na atualidade. EdiPUCRS.
Barros Junior, E. A. (2019). CÓDIGO DE ÉTICA MÉDICA Comentado e interpretado. In Cia do Ebook. Cia do Ebook.
Beauchamp, T. L., & Childress, J. F. (2019). Principles of Biomedical Ethics (8th ed., Vol. 8). Oxford University Press, USA.
CFM. (2015). Análise jurídica. Indicação de medicamento OFF LABEL. Responsabilidade do médico. Caso concreto. Supressão de instância. (pp. 1–4). Conselho Federal de Medicina.
CFM. (2018). CÓDIGO DE ÉTICA MÉDICA RESOLUÇÃO CFM N o22 17 D E 27/0 9/2 0 1 8. Conselho Federal de Medicina.
Conselho Federal de Medicina (CFM). (2020). CFM condiciona uso de cloroquina e hidroxicloroquina a critério médico e consentimento do paciente.
Funck-Brentano, C., & Salem, J.-E. (2020). Chloroquine or hydroxychloroquine for COVID-19: why might they be hazardous? Lancet (London, England), 0(0), 2p. https://doi.org/10.1016/S0140-6736(20)31174-0
Gandhi, R. T., Lynch, J. B., & del Rio, C. (2020). Mild or Moderate Covid-19. New England Journal of Medicine, 383(18), 1757–1766. https://doi.org/10.1056/NEJMcp2009249
Giordano, G., Blanchini, F., Bruno, R., Colaneri, P., Di Filippo, A., Di Matteo, A., & Colaneri, M. (2020). Modelling the COVID-19 epidemic and implementation of population-wide interventions in Italy. Nature Medicine, 26(6), 855–860. https://doi.org/10.1038/s41591-020-0883-7
IDEC. (2019). Código de proteção e defesa do consumidor. Instituto Brasileiro de Defesa do Consumidor.
Magalhães, J. L. de, & Nunes, R. (2014). Tradição e fundamentos éticos hipocráticos aplicáveis à terminalidade da vida. Revista Bioética, 22(3), 448–455. https://doi.org/10.1590/1983-80422014223027
Majeed, A., Seo, Y., Heo, K., & Lee, D. (2020). Can the UK emulate the South Korean approach to covid-19? BMJ, 369(May), m2084. https://doi.org/10.1136/bmj.m2084
Mehra, M. R., Desai, S. S., Ruschitzka, F., & Patel, A. N. (2020). RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. The Lancet, 0(0). https://doi.org/10.1016/S0140-6736(20)31180-6
MS. (2020a). NOTA INFORMATIVA No 5/2020-DAF/SCTIE/MS. Secretaria de Ciência, Tecnologia, Inovação e Insumos Estratégicos Em Saúde Departamento de Assistência Farmacêutica e Insumos Estratégicos; Ministério da Saúde. https://static.poder360.com.br/2020/04/portaria-MS.pdf
MS. (2020b). ORIENTAÇÕES DO MINISTÉRIO DA SAÚDE PARA TRATAMENTO MEDICAMENTOSO PRECOCE DE PACIENTES COM DIAGNÓSTICO DA COVID-19. Minstério da Saúde.
OPAS. (2020). Doença causada pelo novo coronavírus (COVID-19). Organização Pan-Americana Da Saúde. Organização Mundial Da Saúde; Organização Pan-Americana da Saúde / Organização Mundial de Saúde. https://www.paho.org/pt/covid19#:~:text=A COVID-19 é uma,febre%2C cansaço e tosse seca.
Paixão, A. de O. (2001). Consentimento informado em laringectomizados: estudo em um hospital escola. Revista Latino-Americana de Enfermagem, 9(2), 104–109. https://doi.org/10.1590/S0104-11692001000200015
Reis, R. F., de Melo Quintela, B., de Oliveira Campos, J., Gomes, J. M., Rocha, B. M., Lobosco, M., & Weber dos Santos, R. (2020). Characterization of the COVID-19 pandemic and the impact of uncertainties, mitigation strategies, and underreporting of cases in South Korea, Italy, and Brazil. Chaos, Solitons & Fractals, 136, 109888. https://doi.org/10.1016/j.chaos.2020.109888
Sanches, M. A., & Gubert, I. C. (2012). Bioética e vulnerabilidades. Editora UFPR.
Santos, I. E. dos. (2015). Manual de métodos e técnicas de pesquisa científica (11th ed.). Impetus.
Smout, A., & Davey, J. (2020, March). Britain’s NHS could be overwhelmed like Italy, PM Johnson warns on coronavirus - Reuters. Reuters. https://www.reuters.com/article/uk-health-coronavirus-britain-idUKKBN2190AQ
UNESCO. (2006). Declaração Universal sobre Bioética e Direitos Humanos. Organização das Nações Unidas para a Educação, a Ciência e a Cultura.
Yin, R. K. (2015). Estudo de Caso: planejamento e método (5th ed.). Bookman.
Zagury-Orly, I., & Schwartzstein, R. M. (2020). Covid-19 — A Reminder to Reason. New England Journal of Medicine, 383(3), e12. https://doi.org/10.1056/NEJMp2009405
Zhai, M. Z., Lye, C. T., & Kesselheim, A. S. (2020). Need for Transparency and Reliable Evidence in Emergency Use Authorizations for Coronavirus Disease 2019 (COVID-19) Therapies. JAMA Internal Medicine, 180(9), 1145. https://doi.org/10.1001/jamainternmed.2020.2402
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Ângelo Augusto da Silva Araújo; José Rodrigo Santos Silva
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
